RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Recent chinese articleI am expecting quick approval. I love this company and think it has a great future. As soon as they get things going with ibalizumab , i would like to see the company diversify, perhaps buy into other companies in other areas. Perhaps they will use the cash they will generate from their two approved drugs to fund an acquisiton or use stock depending on how high the stock price goes. If it goes to $15+, just a few million shares issues could not only give them a nice war chest, but it could buy one or two promising companies.
Additionally, i really hope they look to move to a better US exchange. I believe if the stock was on the Nasdaq, given what's going on and what we expect to happen with their second approval, the stock price would likely do a lot better. The problem is that many people do not follow this one and i wonder if we aren't getting the analyst coverage because of the exchange we are trading on.